logo-loader
viewCognoptix Inc

Cognoptix developing an Alzheimer’s disease test using the eye

Cognoptix Inc CEO Susanne Wilke sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Concord, Massachusetts-based company develops non-invasive eye tests for the early diagnosis of Alzheimer’s disease.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Pacton Gold announces 11,000 metre drill program for Sidace JV Project

Pacton Gold (CVE: PAC- OTC: PACXF) CEO Dale Ginn joined Steve Darling from Proactive to discuss the news the company is about to begin a new drill program at their joint venture project Sidace in Red Lake. Ginn discusses how big the program will be and where they are planning to drill. Ginn...

1 hour, 20 minutes ago

2 min read